329 related articles for article (PubMed ID: 34588150)
1. Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction.
Thavapalachandran S; Le TYL; Romanazzo S; Rashid FN; Ogawa M; Kilian KA; Brown P; Pouliopoulos J; Barry AM; Fahmy P; Kelly K; Kizana E; Chong JJH
Cytotherapy; 2021 Dec; 23(12):1074-1084. PubMed ID: 34588150
[TBL] [Abstract][Full Text] [Related]
2. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
3. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
5. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
[TBL] [Abstract][Full Text] [Related]
8. FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction.
Deng J; Zhang N; Wang Y; Yang C; Wang Y; Xin C; Zhao J; Jin Z; Cao F; Zhang Z
Stem Cell Res Ther; 2020 Jun; 11(1):228. PubMed ID: 32522253
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
[No Abstract] [Full Text] [Related]
10. Chorion-derived perinatal mesenchymal stem cells improve cardiac function and vascular regeneration: Preferential treatment for ischemic heart disease.
Park YS; Park BW; Choi H; Lee SH; Kim M; Park HJ; Kim IB
Hellenic J Cardiol; 2022; 66():52-58. PubMed ID: 35649476
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.
Liu X; Li X; Zhu W; Zhang Y; Hong Y; Liang X; Fan B; Zhao H; He H; Zhang F
J Cell Physiol; 2020 Nov; 235(11):8010-8022. PubMed ID: 31960418
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
[TBL] [Abstract][Full Text] [Related]
13. The effect of bone marrow- and adipose tissue-derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure.
Karpov AA; Uspenskaya YK; Minasian SM; Puzanov MV; Dmitrieva RI; Bilibina AA; Anisimov SV; Galagudza MM
Int J Exp Pathol; 2013 Jun; 94(3):169-77. PubMed ID: 23560418
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Pretreatment With Stromal-Derived Factor-1 Alpha Augments Cardiac Function and Angiogenesis in Infarcted Myocardium.
Esmaeili R; Darbandi-Azar A; Sadeghpour A; Majidzadeh-A K; Eini L; Jafarbeik-Iravani N; Hoseinpour P; Vajhi A; Oghabi Bakhshaiesh T; Masoudkabir F; Sadeghizadeh M
Am J Med Sci; 2021 Jun; 361(6):765-775. PubMed ID: 33582157
[TBL] [Abstract][Full Text] [Related]
16. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
Sim WS; Park BW; Ban K; Park HJ
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
[TBL] [Abstract][Full Text] [Related]
18. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
